Taipei Exchange - Delayed Quote TWD

GlycoNex Incorporation (4168.TWO)

25.05
-0.95
(-3.65%)
At close: 1:30:34 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
19,032
14,701
2,542
30,085
5,475
Cost of Revenue
5,598
7,380
1,547
16,118
2,014
Gross Profit
13,434
7,321
995
13,967
3,461
Operating Expense
234,132
253,437
260,859
252,608
198,389
Operating Income
-220,698
-246,116
-259,864
-238,641
-194,928
Net Non Operating Interest Income Expense
1,429
2,388
3,654
232
2,735
Pretax Income
-201,454
-229,681
-163,717
-219,822
-172,493
Tax Provision
24
24
14,645
0
0
Net Income Common Stockholders
-201,478
-229,705
-178,362
-219,822
-172,493
Diluted NI Available to Com Stockholders
-201,478
-229,705
-178,362
-219,822
-172,493
Basic EPS
-1.86
-2.12
-1.65
-2.21
-1.78
Diluted EPS
-1.86
-2.12
-1.65
-2.21
-1.78
Basic Average Shares
108,200
108,208
107,831
99,456
96,906.18
Diluted Average Shares
108,200
108,208
107,831
99,456
96,906.18
Total Expenses
239,730
260,817
262,406
268,726
200,403
Net Income from Continuing & Discontinued Operation
-201,478
-229,705
-178,362
-219,822
-172,493
Normalized Income
-201,478
-229,705
-178,362
-219,515
-172,493
Interest Income
7,143
8,096
9,366
4,590
2,735
Interest Expense
5,714
5,708
5,712
4,358
0
Net Interest Income
1,429
2,388
3,654
232
2,735
EBIT
-195,740
-223,973
-158,005
-215,464
-172,493
EBITDA
-160,216
-189,600
-126,827
-175,508
-132,361
Reconciled Cost of Revenue
5,598
7,380
1,547
16,118
2,014
Reconciled Depreciation
35,524
34,373
31,178
39,956
40,132
Net Income from Continuing Operation Net Minority Interest
-201,478
-229,705
-178,362
-219,822
-172,493
Total Unusual Items Excluding Goodwill
--
--
0
-307
0
Total Unusual Items
--
--
0
-307
0
Normalized EBITDA
-160,216
-189,600
-126,827
-175,201
-132,361
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 6/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

6885.TW BRIM Biotechnology, Inc.
34.05
+3.50%
 
6838.TW Formosa Pharmaceuticals, Inc.
34.15
+9.98%
 
3205.TWO Sagittarius Life Science Corp
43.95
+4.02%
 
4133.TW Abnova (Taiwan) Corporation
29.60
-3.58%
 
4171.TWO GeneReach Biotechnology Corp.
22.90
-4.58%
 
1295.TWO Synbio Tech Inc.
106.50
+9.91%
 
1760.TW Panion & Bf Biotech Inc.
78.50
-1.13%
 
4174.TWO OBI Pharma, Inc.
35.35
+2.17%
 
4167.TWO Savior Lifetec Corporation
21.60
+0.93%
 
6535.TWO Lumosa Therapeutics Co., Ltd.
176.50
+1.15%